Cancer cells often undergo metabolic reprogramming to support their rapid proliferation. This is known as the Warburg effect, where cells preferentially use glycolysis for energy production, even in the presence of oxygen. By activating alternative metabolic pathways, cancer cells can generate the necessary building blocks and energy required for growth. Targeting these metabolic changes is a promising area of cancer research.
